Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: Pfizer

Posted on January 15, 2021January 15, 2021

Vaccine dilemma: To take or not to take Covaxin

True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…

Continue Reading
Posted on January 8, 2021

I would not take Covaxin without efficacy data: Gagandeep Kang

Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…

Continue Reading
Posted on January 2, 2021

UK uses an untested strategy to rapidly but partially protect people at risk

With the virus running amok in the country and vaccines in short-supply, the U.K. is attempting an untested strategy of delaying the second dose of both AstraZeneca and Pfizer vaccine even in the absence of data from large trials. The intent is to rapidly but partially protect more individuals who are at risk.

Continue Reading
Posted on December 19, 2020

COVID-19: Ethical challenges of vaccinating people with comorbidities

Unlike in other groups, national databases of people with comorbidities are not available. However, though not comprehensive, since 2010, State governments have been conducting population-based district level screening to detect…

Continue Reading
Posted on December 12, 2020

Can COVID-19 vaccines with EUA be used at the population level?

Meanwhile, the Indian government has spelt out four high-risk groups — healthcare workers, frontline workers, those over 50 years of age and those aged below 50 years but with co-morbidities…

Continue Reading
Posted on December 11, 2020

By putting the vaccine approval on hold for want of data, DCGI has underscored its priorities

The greatly reassuring decision to seek additional safety and immunogenicity data from the Pune-based Serum Institute of India and Hyderabad’s Bharat Biotech underlines the regulator’s priorities even for emergency use…

Continue Reading
Posted on December 8, 2020December 8, 2020

Transparency in COVID-19 vaccine trials vital to gain public trust

Unlike Pfizer, AstraZeneca, which is carrying out the phase-3 trials of the Oxford vaccine in four countries, is yet to secure a nod from any of the regulatory agencies despite…

Continue Reading
Posted on December 5, 2020

COVID-19: Challenges in achieving herd immunity through vaccination

But the government’s idea of vaccinating a “critical mass of people” for the purpose of breaking the virus transmission chain is riddled with problems. Unlike the mRNA vaccines from Pfizer…

Continue Reading

Posts navigation

Page 1 Page 2 Next Page
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,595 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • With more vaccines than vaccinations, India exports Covishield before expiry date January 28, 2021
  • Study finds Covaxin effective against the UK variant January 27, 2021
  • Glitches in CoWIN also responsible for low COVID-19 vaccine uptake January 23, 2021
  • Indian scientists divided over restricted use approval for Covaxin January 15, 2021
  • Vaccine dilemma: To take or not to take Covaxin January 15, 2021

Most Read Posts

  • Study finds Covaxin effective against the UK variant
  • With more vaccines than vaccinations, India exports Covishield before expiry date
  • No correlation between Ct values of PCR test and COVID-19 severity
  • 'Serum’s pneumococcal vaccine will be available by June 2020'
  • UGC’s revised white list has 71 active predatory journals
  • Vaccine dilemma: To take or not to take Covaxin
  • UGC removes 4,305 journals from White list, including the Lancet Public Health
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 10,595 other followers

Archives

Cancel